Por: New York Post Life March 20, 2023
Artificial intelligence has developed a treatment for cancer in just 30 days and can predict a patient’s survival rate. In a new study published in the journal , researchers at the University of Toronto along with Insilico Medicine developed a potential treatment for hepatocellular carcinoma (HCC) with an AI drug discovery platform called Pharma.AI. HCC is the most common type of liver cancer and occurs when a tumor grows on the liver,... + full article
NBC 6 South Florida USA Nation January 17, 2023
>> A STORY GIVING HOPE TO MILLIONS OF AMERICANS, MORE PEOPLE ARE SURVIVING CANCER THAN EVER BEFORE, ACCORDING TO A NEW REPORT FROM THE AMERICAN CANCER SOCIETY. I TALKED TO A DOCTOR WHO SAID ITS A GREAT START BUT THERES WORK TO DO. ITS IMPRESSIVE NEWS. ITS IMPRESSIVE NEWS. THE... + más
What we know about the new COVID-19 variant XBB | The Boston Globe
Cancer death rates down but racial disparities persist among Black men and women | ABC News
ABC News USA Health January 12, 2023
Black men and women are more likely to die from prostate, uterine and breast cancer compared to other races, according to new data from the .That’s despite vast improvements in cancer death rates overall in the United States. Rates of cancer deaths have declined by 33% overall... + más
More people than ever are surviving cancer in the U.S., study shows, as research and treatment see unprecedented progress | CBS News
US breast cancer rate drops 43% in three decades, but racial disparities remain, American Cancer Society report finds | CNN
The Boston Globe USA Nation December 29, 2022
A new coronavirus variant dubbed XBB has swiftly spreading in the Northeast, jumping from about 35 percent of cases during the week ending Dec. 17 to just over half of cases last week, according to .Here’s a quick primer on what we know about the variant.It is more... + más
Highly Immune Evasive Omicron XBB.1.5 Variant Is Quickly Becoming Dominant in U.S. as It Doubles Weekly | NBC 6 South Florida
Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly | CNBC
CBS News USA Health December 07, 2022
Kirstie Alley died from colon cancer, her representative . The actor's family that she had died at age 71, saying the cancer was only recently discovered. An estimated 151,030 people will be diagnosed with colorectal cancer in the U.S. this year, the Colorectal Cancer... + más
John Travolta, Jamie Lee Curtis and other Hollywood stars react to the death of Kirstie Alley | Fox News
Kirstie Alley's death at 71 puts spotlight on colon cancer: What women need to know | ABC News
WPTV USA Nation October 22, 2022
In 2022, there will be an estimated 1.9 million new cancer cases diagnosed, according to the American Cancer Society.Researchers across the U.S. are currently testing vaccines to treat cancer, including breast cancer.“Ten, 20 years ago, if you said the immune system could... + más
Cancer vaccine may be ready by 2030, say founders of COVID vaccine-makers BioNTech | ABC7
Cancer vaccine may be ready by 2030, say founders of COVID vaccine makers BioNTech | ABC News
WPLG Local 10 USA Health October 07, 2022
If you’ve heard of cancer, you’ve heard of breast cancer -- in fact, it’s the most commonly diagnosed cancer among American women. provided that statistic, and has more online. For example, do you know about 1 in 8 U.S. women, roughly 12%, will develop invasive breast... + más
It's Breast Cancer Awareness Month. Here's What to Watch For | NBC 6 South Florida
Mammograms: 3 key questions women should ask before cancer scans | New York Post
CNN USA Health September 22, 2022
(CNN)More people are surviving cancer than ever before in the United States, according to a new report from the American Association for Cancer Research.In the past three years, the number of cancer survivors in the US -- defined as living people who have had a cancer diagnosis... + más
Cancer deaths in US declined by 2% every year since 2016, report says | ABC News
In a nod to JFK, Biden pushing 'moonshot' to fight cancer | 10 WBNS
About iurex | Privacy Policy | Disclaimer |